Premium
Hepatic iron accumulation may be associated with insulin resistance in patients with chronic hepatitis C
Author(s) -
Sumida Yoshio,
Kanemasa Kazuyuki,
Fukumoto Kohei,
Yoshida Naohisa,
Sakai Kyoko
Publication year - 2007
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/j.1872-034x.2007.00152.x
Subject(s) - insulin resistance , medicine , fibrosis , insulin , ferritin , liver biopsy , chronic hepatitis , gastroenterology , hepatic fibrosis , endocrinology , biopsy , immunology , virus
Background/Aim: Insulin resistance and hepatic iron overload are frequently demonstrated in hepatitis C virus (HCV)‐related liver diseases. We investigated the relationship between insulin resistance and hepatic iron deposition in patients with chronic HCV infection. Methods: Insulin resistance was evaluated using the homeostasis model assessments for insulin resistance (HOMA‐IR) in 56 non‐diabetic non‐obese patients with biopsy proven chronic hepatitis C. The relationship between insulin resistance and serum ferritin levels or the grade of hepatic iron deposition was assessed. Results: The levels of plasma immunoreactive insulin (IRI) and HOMA‐IR were significantly correlated with serum ferritin levels and the grade of hepatic iron deposition ( P = 0.003).Although IRI and HOMA‐IR increased in parallel with the development of hepatic fibrosis, insulin resistance (HOMA‐IR > 2) was observed in 11 (26.2%) of 42 patients even without severe fibrosis (F0–2). Among patients without severe fibrosis, IRI and HOMA‐IR were significantly higher in patients with iron deposits than in those without iron deposits. Conclusion: Hepatic iron overload may be associated with insulin resistance in patients with chronic hepatitis C, especially in patients with mild to moderate fibrosis.